ClinicalTrials.Veeva

Menu

Metacognitive Therapy for Patients With Obsessive-Compulsive Disorder

Philipps University logo

Philipps University

Status

Completed

Conditions

Obsessive-Compulsive Disorder

Treatments

Behavioral: Metacognitive Therapy
Behavioral: Exposure and Response Prevention

Study type

Interventional

Funder types

Other

Identifiers

NCT01483339
MCT_OCD_2011

Details and patient eligibility

About

Cognitive behavior therapy is the most effective treatment of obsessive-compulsive disorder. However, the majority of treated patients remain symptomatic. The metacognitive therapy by Wells (1997) could achieve substantial gains in first pilot studies. The purpose of this study is to investigate this approach with a randomized controlled trial by comparing metacognitive therapy with exposure and response prevention for obsessive-compulsive disorder.

Enrollment

37 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Primary diagnosis: obsessive-compulsive disorder
  • German-speaking
  • Agreeing to participate, verified by completion of informed consent

Exclusion criteria

  • Current or past diagnosis of substance dependence, psychosis, neurological conditions
  • Mental retardation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

37 participants in 2 patient groups

Metacognitive Therapy
Experimental group
Treatment:
Behavioral: Metacognitive Therapy
Exposure and Response Prevention
Experimental group
Treatment:
Behavioral: Exposure and Response Prevention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems